Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats
- PMID: 16023291
- DOI: 10.1016/j.neulet.2005.06.029
Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats
Abstract
Usefulness of the in vitro and in vivo generation of neural precursors from embryonic stem (ES) cells has been widely discussed, but functional recovery in animal models of Parkinson's disease (PD) is not fully understood. The aim of this study was to investigate a transplantation strategy for PD by assessing whether double-transplants in the striatum (ST) and substantia nigra (SN), or ST and subthalamic nucleus (STN) induce functional recovery in 6-hydroxydopamine-lesioned rats. Methamphetamine-induced rotation was significantly reduced by transplantation of mouse ES cell-derived neurons into the ST, but not the STN or SN alone. Double-transplantation was also effective at recovering rotational behavior. Although immunoreactivity for tyrosine hydroxylase (TH) was almost completely lost in the ipsilateral striatum in hemiparkinsonian rats, TH immunoreactivity was detected in transplanted cells and sprouting fibers in the ST, STN and SN. These results suggest that both the involvement of ST as a place of transplantation and the number of ES cell-derived neurons are essential factors for efficacy on hemiparkinsonian behaviors.
Similar articles
-
Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants.J Neurosci. 2001 May 15;21(10):3521-30. doi: 10.1523/JNEUROSCI.21-10-03521.2001. J Neurosci. 2001. PMID: 11331381 Free PMC article.
-
Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.J Comp Neurol. 2002 Jan 21;442(4):320-30. doi: 10.1002/cne.10108. J Comp Neurol. 2002. PMID: 11793337
-
Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.Neurosurgery. 2009 Oct;65(4):741-53; discussion 753. doi: 10.1227/01.NEU.0000351281.45986.76. Neurosurgery. 2009. PMID: 19834380
-
Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.Prog Brain Res. 2002;138:411-20. doi: 10.1016/S0079-6123(02)38090-7. Prog Brain Res. 2002. PMID: 12432781 Review. No abstract available.
-
[Surgical treatment of Parkinson's disease].Przegl Lek. 2004;61(12):1383-8. Przegl Lek. 2004. PMID: 15850334 Review. Polish.
Cited by
-
Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.Exp Ther Med. 2017 Mar;13(3):976-982. doi: 10.3892/etm.2017.4073. Epub 2017 Jan 20. Exp Ther Med. 2017. PMID: 28450929 Free PMC article.
-
Extrastriatal dopaminergic circuits of the Basal Ganglia.Front Neuroanat. 2010 Oct 27;4:139. doi: 10.3389/fnana.2010.00139. eCollection 2010. Front Neuroanat. 2010. PMID: 21103009 Free PMC article.
-
Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies.PLoS One. 2024 Feb 13;19(2):e0296297. doi: 10.1371/journal.pone.0296297. eCollection 2024. PLoS One. 2024. PMID: 38349932 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources